Show simple item record

dc.contributor.authorWright, Belinda
dc.contributor.authorMorris, Katrina
dc.contributor.authorGrueber, Catherine E.
dc.contributor.authorWillet, Cali E.
dc.contributor.authorGooley, Rebecca
dc.contributor.authorHogg, Carolyn J.
dc.contributor.authorO’Meally, Denis
dc.contributor.authorHamede, Rodrigo
dc.contributor.authorJones, Menna
dc.contributor.authorWade, Claire
dc.contributor.authorBelov, Katherine
dc.date.accessioned2020-06-29T18:08:55Z
dc.date.available2020-06-29T18:08:55Z
dc.date.issued2015
dc.identifier.issn1471-2164
dc.identifier.doi10.1186/s12864-015-2020-4
dc.identifier.urihttp://hdl.handle.net/20.500.12634/467
dc.description.abstractThe Tasmanian devil (Sarcophilus harrisii) has undergone a recent, drastic population decline due to the highly contagious devil facial tumor disease. The tumor is one of only two naturally occurring transmissible cancers and is almost inevitably fatal. In 2006 a disease-free insurance population was established to ensure that the Tasmanian devil is protected from extinction. The insurance program is dependent upon preserving as much wild genetic diversity as possible to maximize the success of subsequent reintroductions to the wild. Accurate genotypic data is vital to the success of the program to ensure that loss of genetic diversity does not occur in captivity. Until recently, microsatellite markers have been used to study devil population genetics, however as genetic diversity is low in the devil and potentially decreasing in the captive population, a more sensitive genotyping assay is required.
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1186/s12864-015-2020-4
dc.rightsOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectTASMANIAN DEVILS
dc.subjectBREEDING
dc.subjectPOPULATION GENETICS
dc.subjectWILDLIFE CONSERVATION
dc.subjectWILDLIFE MANAGEMENT
dc.subjectTECHNOLOGICAL INNOVATIONS
dc.subjectEXPERIMENTAL METHODS
dc.subjectPOPULATIONS
dc.titleDevelopment of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population
dc.typeArticle
dc.source.journaltitleBMC Genomics
dc.source.volume16
refterms.dateFOA2020-06-29T18:08:56Z
html.description.abstractThe Tasmanian devil (Sarcophilus harrisii) has undergone a recent, drastic population decline due to the highly contagious devil facial tumor disease. The tumor is one of only two naturally occurring transmissible cancers and is almost inevitably fatal. In 2006 a disease-free insurance population was established to ensure that the Tasmanian devil is protected from extinction. The insurance program is dependent upon preserving as much wild genetic diversity as possible to maximize the success of subsequent reintroductions to the wild. Accurate genotypic data is vital to the success of the program to ensure that loss of genetic diversity does not occur in captivity. Until recently, microsatellite markers have been used to study devil population genetics, however as genetic diversity is low in the devil and potentially decreasing in the captive population, a more sensitive genotyping assay is required.


Files in this item

Thumbnail
Name:
Wright_2015_BMCGenomics.pdf
Size:
914.7Kb
Format:
PDF

This item appears in the following Collection(s)

  • SDZWA Research Publications
    Peer reviewed and scientific works by San Diego Zoo Wildlife Alliance staff. Includes books, book sections, articles and conference publications and presentations.

Show simple item record

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Except where otherwise noted, this item's license is described as Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.